Your browser doesn't support javascript.
loading
Should We Adapt the Prescription Criteria for Specific Treatments for Migraine Due to the COVID-19 Pandemic?
Porta-Etessam, Jesús; Gonzalez-Garcia, Nuria; Matias-Guiu, Jordi A; Montero-Escribano, Paloma; Matías-Guiu, Jorge.
Afiliação
  • Porta-Etessam J; Department of Neurology, San Carlos Health Research Institute, Universidad Complutense, Madrid, Spain.
  • Gonzalez-Garcia N; Department of Neurology, San Carlos Health Research Institute, Universidad Complutense, Madrid, Spain.
  • Matias-Guiu JA; Department of Neurology, San Carlos Health Research Institute, Universidad Complutense, Madrid, Spain.
  • Montero-Escribano P; Department of Neurology, San Carlos Health Research Institute, Universidad Complutense, Madrid, Spain.
  • Matías-Guiu J; Department of Neurology, San Carlos Health Research Institute, Universidad Complutense, Madrid, Spain.
Headache ; 60(7): 1448-1449, 2020 07.
Article em En | MEDLINE | ID: mdl-32526038
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Toxinas Botulínicas Tipo A / COVID-19 / Transtornos de Enxaqueca Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Toxinas Botulínicas Tipo A / COVID-19 / Transtornos de Enxaqueca Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article